SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-293200
Filing Date
2021-10-06
Accepted
2021-10-06 16:21:09
Documents
12
Period of Report
2021-10-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d212272d8k.htm   iXBRL 8-K 27605
  Complete submission text file 0001193125-21-293200.txt   147459

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zsan-20211005.xsd EX-101.SCH 2903
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20211005_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20211005_pre.xml EX-101.PRE 10960
5 EXTRACTED XBRL INSTANCE DOCUMENT d212272d8k_htm.xml XML 3270
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 211309973
SIC: 2834 Pharmaceutical Preparations